Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Accelagen Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Prescription medicine registration (31)
ARTG (30)
Cancellation by sponsor (5)
Australian Public Assessment Report (AusPAR) (1)
COVID-19 test kit (1)
Prescription medicine decision summary (1)

Date

2026 (21)
2025 (11)
2023 (1)
2022 (9)
2021 (11)
2020 (9)
2019 (3)
2001 (4)

Search

Sponsor content

69 result(s) found, displaying 31 to 40

APO-SAFINAMIDE (Accelagen Pty Ltd)

24 June 2025

Prescription medicine registration

Active ingredients: safinamide mesilate.
BRIUMVI (Accelagen Pty Ltd)

4 June 2025

Prescription medicine registration

Active ingredients: ublituximab.
Accelagen Pty Ltd - Severe acute respiratory syndrome-associated coronavirus IVDs Cancelled under Section 41GL(d) of the Act

2 May 2023

Cancellation by sponsor

Requested by Accelagen Pty Ltd
DIMETHYL FUMARATE MSN dimethyl fumarate 240 mg enteric capsule blister pack (324440)

20 April 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DIMETHYL FUMARATE MSN dimethyl fumarate 240 mg enteric capsule blister pack.
DIMETHYL FUMARATE MSN dimethyl fumarate 240 mg enteric capsule bottle (324443)

20 April 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DIMETHYL FUMARATE MSN dimethyl fumarate 240 mg enteric capsule bottle.
DIMETHYL FUMARATE MSN dimethyl fumarate 120 mg enteric capsule blister pack (324441)

20 April 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DIMETHYL FUMARATE MSN dimethyl fumarate 120 mg enteric capsule blister pack.
DIMETHYL FUMARATE MSN dimethyl fumarate 120 mg enteric capsule bottle (324442)

20 April 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DIMETHYL FUMARATE MSN dimethyl fumarate 120 mg enteric capsule bottle.
FOSAPREPITANT MSN (Accelagen Pty Ltd)

7 October 2022

Prescription medicine registration

Active ingredients: Fosaprepitant dimeglumine.
TICALOR; BLOOMS THE CHEMIST TICAGRELOR; APO-TICAGRELOR; TICAGRELOR ARX (Accelagen Pty Ltd)

4 October 2022

Prescription medicine registration

Active ingredients: Ticagrelor.
SUNITINIB MSN sunitinib (as malate) 50 mg hard capsule bottle (Accelagen Pty Ltd)

18 July 2022

Prescription medicine registration

Active ingredients: Sunitinib malate.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.